1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Kim, S. Jao, S. Laurence, J.S. LiWang, P.J. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 40 10782 10791 10.1021/bi011065x 11535053 Structural comparison of monomeric variants of the chemokine MIP-1beta having differing ability to bind the receptor CCR5. 2001 US Biochemistry BICHAW 0033 0006-2960 39 3401 3409 10.1021/bi9923196 CC chemokine MIP-1beta can function as a monomer and depends on Phe13 for receptor binding 2000 US Science SCIEAS 0038 0036-8075 263 1762 1767 High-resolution solution structure of the beta chemokine hMIP-1beta by multidimensional NMR 1994 10.2210/pdb1je4/pdb pdb_00001je4 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 7748.646 macrophage inflammatory protein 1-beta F13A 1 man polymer MIP-1beta, T-CELL ACTIVATION PROTEIN 2, ACT-2, LYMPHOCYTE ACTIVATION GENE-1 PROTEIN, LAG-1 no no APMGSDPPTACCASYTARKLPRNFVVDYYETSSLCSQPAVVFQTKRSKQVCADPSESWVQEYVYDLELN APMGSDPPTACCASYTARKLPRNFVVDYYETSSLCSQPAVVFQTKRSKQVCADPSESWVQEYVYDLELN A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia Escherichia coli sample 9606 Homo sapiens 469008 Escherichia coli BL21(DE3) BL21 (DE3) plasmid pET32 database_2 pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Database references Derived calculations 1 0 2001-10-03 1 1 2008-04-27 1 2 2011-07-13 1 3 2021-10-27 _database_2.pdbx_DOI _database_2.pdbx_database_accession _struct_ref_seq_dif.details 1HUM is the dimeric MIP-1beta wild-type protein. 1VMP binds to CCR5 which is a natural receptor of MIP-1beta. RCSB Y RCSB 2001-06-15 REL REL This structure was determined using standard 3D 15N or 13C edited NMR experiments. 1 3D_13C-separated_NOESY 3D_15N-separated_NOESY HNHA 20mM sodium phosphate 2.5 ambient 298 K The structure is based on a total 940 restraints, 851 distance constraints, 69 dihedral angle restraints, 20 distance restraints for 10 hydrogen bonds. The initial fold was obtained by distance geometry and further refined by simulated annealing. minimized average structure 1-2mM MIP-1b F13A U-15N, 13C; 20mM Na-phosphate buffer 90% H2O/10% D2O Delaglio processing NMRPipe Brunger structure solution CNS 1.0 Brunger refinement CNS 1.0 500 Varian INOVA 600 Varian INOVA ALA 1 n 1 ALA 1 A PRO 2 n 2 PRO 2 A MET 3 n 3 MET 3 A GLY 4 n 4 GLY 4 A SER 5 n 5 SER 5 A ASP 6 n 6 ASP 6 A PRO 7 n 7 PRO 7 A PRO 8 n 8 PRO 8 A THR 9 n 9 THR 9 A ALA 10 n 10 ALA 10 A CYS 11 n 11 CYS 11 A CYS 12 n 12 CYS 12 A ALA 13 n 13 ALA 13 A SER 14 n 14 SER 14 A TYR 15 n 15 TYR 15 A THR 16 n 16 THR 16 A ALA 17 n 17 ALA 17 A ARG 18 n 18 ARG 18 A LYS 19 n 19 LYS 19 A LEU 20 n 20 LEU 20 A PRO 21 n 21 PRO 21 A ARG 22 n 22 ARG 22 A ASN 23 n 23 ASN 23 A PHE 24 n 24 PHE 24 A VAL 25 n 25 VAL 25 A VAL 26 n 26 VAL 26 A ASP 27 n 27 ASP 27 A TYR 28 n 28 TYR 28 A TYR 29 n 29 TYR 29 A GLU 30 n 30 GLU 30 A THR 31 n 31 THR 31 A SER 32 n 32 SER 32 A SER 33 n 33 SER 33 A LEU 34 n 34 LEU 34 A CYS 35 n 35 CYS 35 A SER 36 n 36 SER 36 A GLN 37 n 37 GLN 37 A PRO 38 n 38 PRO 38 A ALA 39 n 39 ALA 39 A VAL 40 n 40 VAL 40 A VAL 41 n 41 VAL 41 A PHE 42 n 42 PHE 42 A GLN 43 n 43 GLN 43 A THR 44 n 44 THR 44 A LYS 45 n 45 LYS 45 A ARG 46 n 46 ARG 46 A SER 47 n 47 SER 47 A LYS 48 n 48 LYS 48 A GLN 49 n 49 GLN 49 A VAL 50 n 50 VAL 50 A CYS 51 n 51 CYS 51 A ALA 52 n 52 ALA 52 A ASP 53 n 53 ASP 53 A PRO 54 n 54 PRO 54 A SER 55 n 55 SER 55 A GLU 56 n 56 GLU 56 A SER 57 n 57 SER 57 A TRP 58 n 58 TRP 58 A VAL 59 n 59 VAL 59 A GLN 60 n 60 GLN 60 A GLU 61 n 61 GLU 61 A TYR 62 n 62 TYR 62 A VAL 63 n 63 VAL 63 A TYR 64 n 64 TYR 64 A ASP 65 n 65 ASP 65 A LEU 66 n 66 LEU 66 A GLU 67 n 67 GLU 67 A LEU 68 n 68 LEU 68 A ASN 69 n 69 ASN 69 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 A O TYR 29 A O TYR 29 A N VAL 41 A N VAL 41 A N VAL 40 A N VAL 40 A O ALA 52 A O ALA 52 1 A ASP 6 -147.62 58.19 1 A ALA 10 -165.58 32.26 1 A ALA 17 -97.14 37.86 1 A PHE 24 -97.26 30.74 1 A VAL 26 -90.03 -64.25 1 A SER 32 -60.33 -170.09 1 A ASP 53 -57.79 109.08 minimized average Solution structure of the monomeric variant of the chemokine MIP-1beta 1 N N A PRO 21 A PRO 21 HELX_P A ASN 23 A ASN 23 5 1 3 A GLU 56 A GLU 56 HELX_P A LEU 68 A LEU 68 1 2 13 disulf 2.030 A CYS 11 A SG CYS 11 1_555 A CYS 35 A SG CYS 35 1_555 disulf 2.031 A CYS 12 A SG CYS 12 1_555 A CYS 51 A SG CYS 51 1_555 ANTIVIRAL PROTEIN MIP-1beta, chemokine, macrophage inflammatory protein, ANTIVIRAL PROTEIN CCL4_HUMAN UNP 1 24 P13236 APMGSDPPTACCFSYTARKLPRNFVVDYYETSSLCSQPAVVFQTKRSKQVCADPSESWVQEYVYDLELN 24 92 1JE4 1 69 P13236 A 1 1 69 1 PHE engineered mutation ALA 13 1JE4 A P13236 UNP 36 13 3 anti-parallel anti-parallel A VAL 25 A VAL 25 A GLU 30 A GLU 30 A VAL 40 A VAL 40 A THR 44 A THR 44 A CYS 51 A CYS 51 A ALA 52 A ALA 52